Coya Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.27 | -100% | -5.76 | -100% |
| P/S |
|
12.11 | 33.44 | -63.79% |
|
|
| P/BV |
|
2.04 | 4.64 | -56.09% |
|
|
| P/FCF |
|
0 | 42.53 | -100% |
|
|
| Ev/Ebitda |
|
-5.46 | -17.68 | -69.11% |
|
|
| Ev/S |
|
6.67 | 22.59 | -70.47% |
|
|
| Ev/FCF |
|
-3.58 | 47.55 | -107.53% |
|
|
| E/P |
|
0 | 0.0182 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-122.17 | -14.2 | 760.11% | -126.69 | -3.57% |
| ROE |
|
-22.41 | 9.78 | -329.06% |
|
|
| ROA |
|
-19.35 | 0.33 | -5963.8% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-133.08 | -26.41 | 403.83% |
|
|
| ROCE |
|
-20.65 | 14.55 | -241.93% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-1.77 | -3.87 | -54.23% | -1.48 | +19.52% |
| Nеt Debt/Ebitda |
|
4.45 | -4.24 | -204.93% |
|
|
| Debt/Ratio |
|
0.315 | 0.1853 | 69.98% |
|
|
| Debt/Equity |
|
0 | 1.61 | -100% |
|
|
| Debt/Net Income |
|
-1.63 | 10.06 | -116.18% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5351 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.235 | -100% |
|
|
| Average dividend growth |
|
0 | 1.41 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.486 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5351 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | 30.62 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
1033.24 | -17.42 | -6031.34% | ||
| Growth impulse Net Income in 5 years |
|
989.75 | -52.26 | -1993.9% | ||
| Growth impulse FCF in 5 years |
|
2761.59 | -31.68 | -8817.14% | ||
| Growth impulse EPS in 5 years |
|
938.19 | -61.82 | -1617.62% |
IP Score
4.23/10
